Skip to main content

What the FDA labels say about taking them together

Sufentanil and voriconazole

Voriconazole's FDA label of February 26, 2026 names sufentanil in its drug interactions section; the sufentanil label PlainMeds reads does not name voriconazole. The voriconazole label: “Reduction in the dose of alfentanil and other opiates metabolized by CYP3A4 (e.g., sufentanil) should be considered when concomitantly administered with VFEND.”

Check it at the source: the sufentanil FDA label on DailyMed (effective June 1, 2026, Hospira, Inc.); the voriconazole FDA label on DailyMed (effective February 26, 2026, Roerig).

What does the sufentanil label say about voriconazole?

Sufentanil's label (effective June 1, 2026) does not name voriconazole in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Sufentanil Citrate), Hospira, Inc., effective June 1, 2026 (SPL set 20293943-46ff-4345-1aa4-929b4e017a25), via openFDA; the full label on DailyMed

What does the voriconazole label say about sufentanil?

Voriconazole label, drug interactions

Reduction in the dose of alfentanil and other opiates metabolized by CYP3A4 (e.g., sufentanil) should be considered when concomitantly administered with VFEND.

Source: FDA drug label (Voriconazole, NDA208562), Xellia Pharmaceuticals USA LLC, effective January 11, 2023 (SPL set 9ec6eda2-2f15-423b-9ec6-819379a426e1), via openFDA

Source: FDA drug label (VFEND), NDA021630 (Pf Prism Cv), as published by Roerig, effective February 26, 2026 (SPL set ce3ef5cf-3087-4d92-9d94-9eb8287228db), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

1Sufentanil generic labelers
31Voriconazole generic labelers
SufentanilVoriconazole
Labeled forn/aFungal infections
Boxed warningYesNo
Pharmacy cost (NADAC)n/a$1.88 per tablet 200 mg tablet
Shortage nowIn shortageA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?